The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines
Rødland, Gro Elise, Melhus, Katrine, Generalov, Roman, Gilani, Sania, Bertoni, Francesco, Dahle, Jostein, Syljuåsen, Randi G., Patzke, SebastianVolume:
9
Journal:
Frontiers in Oncology
DOI:
10.3389/fonc.2019.01301
Date:
November, 2019
File:
PDF, 2.29 MB
2019